Debt-to-equity of Praxis Precision Medicines, Inc. from 30 Jun 2021 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Praxis Precision Medicines, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2021 to 31 Dec 2025.
  • Praxis Precision Medicines, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 9.7%, a 26% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Praxis Precision Medicines, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 9.7% +2% +26% 31 Dec 2025
Q3 2025 11% +2.4% +27% 30 Sep 2025
Q2 2025 9.5% -0.52% -5.1% 30 Jun 2025
Q1 2025 7.9% -9.8% -55% 31 Mar 2025
Q4 2024 7.7% -23% -75% 31 Dec 2024
Q3 2024 8.6% -28% -76% 30 Sep 2024
Q2 2024 10% -28% -73% 30 Jun 2024
Q1 2024 18% -20% -54% 31 Mar 2024
Q4 2023 31% -0.82% -2.6% 31 Dec 2023
Q3 2023 36% +12% +52% 30 Sep 2023
Q2 2023 38% +19% +106% 30 Jun 2023
Q1 2023 38% +25% +194% 31 Mar 2023
Q4 2022 31% +22% +247% 31 Dec 2022
Q3 2022 24% +17% +263% 30 Sep 2022
Q2 2022 18% +10% +134% 30 Jun 2022
Q1 2022 13% 31 Mar 2022
Q4 2021 9.1% 31 Dec 2021
Q3 2021 6.6% 30 Sep 2021
Q2 2021 7.8% 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.